ВОЗМОЖНОСТИ ЛЕЧЕНИЯ БОЛЬНЫХ РАКОМ ЖЕЛУДКА С МЕТАСТАЗАМИ В КОСТИ СКЕЛЕТАsystemic radionuclide therapy

ОЦЕНКА ЭФФЕКТИВНОСТИ ЛЕЧЕНИЯ КОСТНЫХ МЕТАСТАЗОВ САМАРИЕМ-153 ОКСАБИФОРОМ В СОЧЕТАНИИ С БИСФОСФОНАТАМИ И ПРИ МОНОРЕЖИМЕ С ПОМОЩЬЮ ПОЛУКОЛИЧЕСТВЕННОГО АНАЛИЗА ОСТЕОСЦИНТИГРАММESTIMATION OF SAMARIUM-153 OXABIFORE THERAPY RESULTS OF METASTATIC BONE DISEASE IN COMBINED

of the potential of immune system-derived miRNAs to revolutionize CVD management and therapy, addressing a major

effectively target various structures within the central nervous system (CNS). MiRNA-based therapy stands out

classification began to take shape in the twentieth century thanks to the integrative system of V.P. Kashchenko

The paper discusses the features of antithrombotic therapy of pregnant women suffering from

ПЕРСПЕКТИВНЫЕ НАПРАВЛЕНИЯ ПАТОГЕНЕТИЧЕСКОГО ЛЕЧЕНИЯ ДИАБЕТИЧЕСКОЙ РЕТИНОПАТИИ И ДИАБЕТИЧЕСКОГО МАКУЛЯРНОГО ОТЕКАanti-VEGF therapy

-tumor barrier (BTB), which limit the efficacy of systemic therapies. Recent advances in molecular biology

ЭКУЛИЗУМАБ В ТЕРАПИИ ПАТОЛОГИИ СИСТЕМЫ КОМПЛЕМЕНТА ПРИ ПАРОКСИЗМАЛЬНОЙ НОЧНОЙ ГЕМОГЛОБИНУРИИECULIZUMAB IN THE TREATMENT OF COMPLEMENT SYSTEM DISORDERS INCLUDING PAROXYSMAL NOCTURNAL

the search for new therapeutic strategies for a disease-modifying therapy for treatment-resistant Sch (TRS